Neurovascular Embolization Devices Market Size, Share and Growth Outlook 2026: By Product, By Therapeutic Application, By Procedure, By End User, Companies to 2034
The global Neurovascular Embolization Devices Market size is forecast to increase from $3.1 Billion in 2026 to $5.59 Billion in 2034 at a CAGR of 7.64% between 2026 and 2034.
The Neurovascular Embolization Devices market report provides detailed analysis and outlook of Neurovascular Embolization Devices segments including By Product (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents/Systems, Aneurysm Clips, Intrasaccular Flow Disruptors, Cerebral Balloon Angioplasty and Stenting Systems, Carotid Artery Stents, Embolic Protection Systems, Distal Filter Devices, Support Devices ), By Therapeutic Application (Aneurysm, Arteriovenous Malformations (AVMs), Ischemic Stroke, Stenosis), By Procedure (Aneurysm Coiling and Embolization, AVM Embolization, Other Procedures), By End User (Hospitals, Specialty Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neurovascular Embolization Devices Industry Overview
Rising Demand for Minimally Invasive Neurointerventions Supports Market Expansion
The neurovascular embolization devices industry plays a critical role in the treatment of cerebral aneurysms, arteriovenous malformations, stroke-related conditions, vascular malformations, and other complex neurovascular disorders. Increasing preference for minimally invasive procedures has accelerated adoption of embolization technologies that allow physicians to access and treat intricate vascular structures through catheter-based approaches. The industry encompasses embolic coils, liquid embolic agents, flow diversion systems, microcatheters, guidewires, and neurovascular access devices that support precision treatment within highly tortuous cerebral anatomy. Growing incidence of stroke and neurovascular diseases, combined with advances in neurointerventional techniques and imaging technologies, continues to drive investment in increasingly sophisticated embolization platforms designed to improve procedural outcomes and patient recovery.
Strategic Consolidation Is Strengthening Neurovascular Treatment Ecosystems
Industry consolidation has become a significant trend as major medical device manufacturers seek to build comprehensive neurovascular portfolios. Medtronic announced plans to acquire Scientia Vascular, bringing specialized guidewire and microcatheter technologies into its existing neurovascular platform. The integration is designed to improve device navigation through complex cerebral vasculature and support more efficient neurointerventional procedures. Similarly, Boston Scientific entered into an agreement to acquire Penumbra, a company recognized for its thrombectomy, embolization, and vascular access technologies. These strategic transactions demonstrate increasing emphasis on creating end-to-end neurovascular treatment ecosystems that combine access, navigation, embolization, and therapeutic intervention capabilities within a unified portfolio. Such consolidation is expected to strengthen procedural efficiency while expanding treatment options for physicians managing complex neurovascular diseases.
Access Technologies and Embolization Platforms Drive Clinical Innovation
Advancements in neurovascular embolization increasingly depend on improvements in access devices and procedural support technologies. The ability to safely navigate highly tortuous cerebral anatomy remains a key requirement for successful embolization procedures, creating demand for advanced microcatheters, guidewires, and delivery systems. Penumbra’s continued commercial momentum highlights the growing utilization of embolization and access technologies across global neurovascular practices, with strong growth reported within this segment. These devices support a broad range of interventions involving aneurysm treatment, stroke management, and vascular occlusion procedures. As physicians pursue increasingly complex neurovascular interventions, manufacturers are focusing on enhancing navigability, procedural control, deliverability, and treatment precision. The combination of improved access technologies, strategic portfolio expansion, and growing procedural volumes is positioning neurovascular embolization devices as essential tools within modern neurointerventional care.
Neurovascular Embolization Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neurovascular Embolization Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), Penumbra, Inc., Terumo Corporation (MicroVention), Boston Scientific Corporation, MicroPort Scientific Corporation, Balt SAS, phenox GmbH, Medikit Co., Ltd.. The Neurovascular Embolization Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neurovascular Embolization Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Neurovascular Embolization Devices industry include- Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), Penumbra, Inc., Terumo Corporation (MicroVention), Boston Scientific Corporation, MicroPort Scientific Corporation, Balt SAS, phenox GmbH, Medikit Co., Ltd.. The Neurovascular Embolization Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neurovascular Embolization Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neurovascular Embolization Devices market remains one of the strongest-performing segments in the country.
The US Neurovascular Embolization Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neurovascular Embolization Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neurovascular Embolization Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neurovascular Embolization Devices markets
Canada's strong Neurovascular Embolization Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neurovascular Embolization Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neurovascular Embolization Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neurovascular Embolization Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neurovascular Embolization Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neurovascular Embolization Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neurovascular Embolization Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neurovascular Embolization Devices sales through 2034
France Neurovascular Embolization Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neurovascular Embolization Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neurovascular Embolization Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neurovascular Embolization Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neurovascular Embolization Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neurovascular Embolization Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neurovascular Embolization Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neurovascular Embolization Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neurovascular Embolization Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neurovascular Embolization Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neurovascular Embolization Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neurovascular Embolization Devices Market Segmentation
By Product
Embolic Coils
Flow Diversion Devices
Liquid Embolic Agents/Systems
Aneurysm Clips
Intrasaccular Flow Disruptors
Cerebral Balloon Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Systems
Distal Filter Devices
Support Devices
By Therapeutic Application
Aneurysm
Arteriovenous Malformations (AVMs)
Ischemic Stroke
Stenosis
By Procedure
Aneurysm Coiling and Embolization
AVM Embolization
Other Procedures
By End User
Hospitals
Specialty Clinics
Leading Companies in Neurovascular Embolization Devices Industry (2026)
Medtronic plc
Stryker Corporation
Johnson & Johnson (Cerenovus)
Penumbra, Inc.
Terumo Corporation (MicroVention)
Boston Scientific Corporation
MicroPort Scientific Corporation
Balt SAS
phenox GmbH
Medikit Co., Ltd.
Countries Included
The Neurovascular Embolization Devices market report provides detailed analysis and outlook of Neurovascular Embolization Devices segments including By Product (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents/Systems, Aneurysm Clips, Intrasaccular Flow Disruptors, Cerebral Balloon Angioplasty and Stenting Systems, Carotid Artery Stents, Embolic Protection Systems, Distal Filter Devices, Support Devices ), By Therapeutic Application (Aneurysm, Arteriovenous Malformations (AVMs), Ischemic Stroke, Stenosis), By Procedure (Aneurysm Coiling and Embolization, AVM Embolization, Other Procedures), By End User (Hospitals, Specialty Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neurovascular Embolization Devices Industry Overview
Rising Demand for Minimally Invasive Neurointerventions Supports Market Expansion
The neurovascular embolization devices industry plays a critical role in the treatment of cerebral aneurysms, arteriovenous malformations, stroke-related conditions, vascular malformations, and other complex neurovascular disorders. Increasing preference for minimally invasive procedures has accelerated adoption of embolization technologies that allow physicians to access and treat intricate vascular structures through catheter-based approaches. The industry encompasses embolic coils, liquid embolic agents, flow diversion systems, microcatheters, guidewires, and neurovascular access devices that support precision treatment within highly tortuous cerebral anatomy. Growing incidence of stroke and neurovascular diseases, combined with advances in neurointerventional techniques and imaging technologies, continues to drive investment in increasingly sophisticated embolization platforms designed to improve procedural outcomes and patient recovery.
Strategic Consolidation Is Strengthening Neurovascular Treatment Ecosystems
Industry consolidation has become a significant trend as major medical device manufacturers seek to build comprehensive neurovascular portfolios. Medtronic announced plans to acquire Scientia Vascular, bringing specialized guidewire and microcatheter technologies into its existing neurovascular platform. The integration is designed to improve device navigation through complex cerebral vasculature and support more efficient neurointerventional procedures. Similarly, Boston Scientific entered into an agreement to acquire Penumbra, a company recognized for its thrombectomy, embolization, and vascular access technologies. These strategic transactions demonstrate increasing emphasis on creating end-to-end neurovascular treatment ecosystems that combine access, navigation, embolization, and therapeutic intervention capabilities within a unified portfolio. Such consolidation is expected to strengthen procedural efficiency while expanding treatment options for physicians managing complex neurovascular diseases.
Access Technologies and Embolization Platforms Drive Clinical Innovation
Advancements in neurovascular embolization increasingly depend on improvements in access devices and procedural support technologies. The ability to safely navigate highly tortuous cerebral anatomy remains a key requirement for successful embolization procedures, creating demand for advanced microcatheters, guidewires, and delivery systems. Penumbra’s continued commercial momentum highlights the growing utilization of embolization and access technologies across global neurovascular practices, with strong growth reported within this segment. These devices support a broad range of interventions involving aneurysm treatment, stroke management, and vascular occlusion procedures. As physicians pursue increasingly complex neurovascular interventions, manufacturers are focusing on enhancing navigability, procedural control, deliverability, and treatment precision. The combination of improved access technologies, strategic portfolio expansion, and growing procedural volumes is positioning neurovascular embolization devices as essential tools within modern neurointerventional care.
Neurovascular Embolization Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neurovascular Embolization Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), Penumbra, Inc., Terumo Corporation (MicroVention), Boston Scientific Corporation, MicroPort Scientific Corporation, Balt SAS, phenox GmbH, Medikit Co., Ltd.. The Neurovascular Embolization Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neurovascular Embolization Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Neurovascular Embolization Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Neurovascular Embolization Devices companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Neurovascular Embolization Devices markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Neurovascular Embolization Devices industry include- Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), Penumbra, Inc., Terumo Corporation (MicroVention), Boston Scientific Corporation, MicroPort Scientific Corporation, Balt SAS, phenox GmbH, Medikit Co., Ltd.. The Neurovascular Embolization Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neurovascular Embolization Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neurovascular Embolization Devices market remains one of the strongest-performing segments in the country.
The US Neurovascular Embolization Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neurovascular Embolization Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neurovascular Embolization Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neurovascular Embolization Devices markets
Canada's strong Neurovascular Embolization Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neurovascular Embolization Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neurovascular Embolization Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neurovascular Embolization Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neurovascular Embolization Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neurovascular Embolization Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neurovascular Embolization Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neurovascular Embolization Devices sales through 2034
France Neurovascular Embolization Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neurovascular Embolization Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neurovascular Embolization Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neurovascular Embolization Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neurovascular Embolization Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neurovascular Embolization Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neurovascular Embolization Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neurovascular Embolization Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neurovascular Embolization Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neurovascular Embolization Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neurovascular Embolization Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neurovascular Embolization Devices Market Segmentation
By Product
Embolic Coils
Flow Diversion Devices
Liquid Embolic Agents/Systems
Aneurysm Clips
Intrasaccular Flow Disruptors
Cerebral Balloon Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Systems
Distal Filter Devices
Support Devices
By Therapeutic Application
Aneurysm
Arteriovenous Malformations (AVMs)
Ischemic Stroke
Stenosis
By Procedure
Aneurysm Coiling and Embolization
AVM Embolization
Other Procedures
By End User
Hospitals
Specialty Clinics
Leading Companies in Neurovascular Embolization Devices Industry (2026)
Medtronic plc
Stryker Corporation
Johnson & Johnson (Cerenovus)
Penumbra, Inc.
Terumo Corporation (MicroVention)
Boston Scientific Corporation
MicroPort Scientific Corporation
Balt SAS
phenox GmbH
Medikit Co., Ltd.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neurovascular Embolization Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neurovascular Embolization Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neurovascular Embolization Devices Markets in 2026
3.2. Global Historic and Forecast Neurovascular Embolization Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neurovascular Embolization Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neurovascular Embolization Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neurovascular Embolization Devices Value Chain
CHAPTER 4- NEUROVASCULAR EMBOLIZATION DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neurovascular Embolization Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROVASCULAR EMBOLIZATION DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product
Embolic Coils
Flow Diversion Devices
Liquid Embolic Agents/Systems
Aneurysm Clips
Intrasaccular Flow Disruptors
Cerebral Balloon Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Systems
Distal Filter Devices
Support Devices
By Therapeutic Application
Aneurysm
Arteriovenous Malformations (AVMs)
Ischemic Stroke
Stenosis
By Procedure
Aneurysm Coiling and Embolization
AVM Embolization
Other Procedures
By End User
Hospitals
Specialty Clinics
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neurovascular Embolization Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
7.5. North America Neurovascular Embolization Devices Market Size Outlook by Type
7.6. North America Neurovascular Embolization Devices Market Size Outlook by Application
7.7. North America Neurovascular Embolization Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neurovascular Embolization Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neurovascular Embolization Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neurovascular Embolization Devices Companies
CHAPTER 8- EUROPE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neurovascular Embolization Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Neurovascular Embolization Devices Market Size Outlook by Type
8.6. Europe Neurovascular Embolization Devices Market Size Outlook by Application
8.7. Europe Neurovascular Embolization Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neurovascular Embolization Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neurovascular Embolization Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neurovascular Embolization Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neurovascular Embolization Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neurovascular Embolization Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neurovascular Embolization Devices Companies
CHAPTER 9- ASIA PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neurovascular Embolization Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Type
9.6. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Application
9.7. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neurovascular Embolization Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neurovascular Embolization Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neurovascular Embolization Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neurovascular Embolization Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neurovascular Embolization Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neurovascular Embolization Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neurovascular Embolization Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neurovascular Embolization Devices Market Size Outlook by Type
10.6. South and Central America Neurovascular Embolization Devices Market Size Outlook by Application
10.7. South and Central America Neurovascular Embolization Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neurovascular Embolization Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neurovascular Embolization Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neurovascular Embolization Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neurovascular Embolization Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Type
11.6. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Application
11.7. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neurovascular Embolization Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neurovascular Embolization Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neurovascular Embolization Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neurovascular Embolization Devices Industry
Medtronic plc
Stryker Corporation
Johnson & Johnson (Cerenovus)
Penumbra, Inc.
Terumo Corporation (MicroVention)
Boston Scientific Corporation
MicroPort Scientific Corporation
Balt SAS
phenox GmbH
Medikit Co., Ltd.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neurovascular Embolization Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neurovascular Embolization Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neurovascular Embolization Devices Markets in 2026
3.2. Global Historic and Forecast Neurovascular Embolization Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neurovascular Embolization Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neurovascular Embolization Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neurovascular Embolization Devices Value Chain
CHAPTER 4- NEUROVASCULAR EMBOLIZATION DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neurovascular Embolization Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROVASCULAR EMBOLIZATION DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product
Embolic Coils
Flow Diversion Devices
Liquid Embolic Agents/Systems
Aneurysm Clips
Intrasaccular Flow Disruptors
Cerebral Balloon Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Systems
Distal Filter Devices
Support Devices
By Therapeutic Application
Aneurysm
Arteriovenous Malformations (AVMs)
Ischemic Stroke
Stenosis
By Procedure
Aneurysm Coiling and Embolization
AVM Embolization
Other Procedures
By End User
Hospitals
Specialty Clinics
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neurovascular Embolization Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
7.5. North America Neurovascular Embolization Devices Market Size Outlook by Type
7.6. North America Neurovascular Embolization Devices Market Size Outlook by Application
7.7. North America Neurovascular Embolization Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neurovascular Embolization Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neurovascular Embolization Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neurovascular Embolization Devices Companies
CHAPTER 8- EUROPE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neurovascular Embolization Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Neurovascular Embolization Devices Market Size Outlook by Type
8.6. Europe Neurovascular Embolization Devices Market Size Outlook by Application
8.7. Europe Neurovascular Embolization Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neurovascular Embolization Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neurovascular Embolization Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neurovascular Embolization Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neurovascular Embolization Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neurovascular Embolization Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neurovascular Embolization Devices Companies
CHAPTER 9- ASIA PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neurovascular Embolization Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Type
9.6. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Application
9.7. Asia Pacific Neurovascular Embolization Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neurovascular Embolization Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neurovascular Embolization Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neurovascular Embolization Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neurovascular Embolization Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neurovascular Embolization Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neurovascular Embolization Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neurovascular Embolization Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neurovascular Embolization Devices Market Size Outlook by Type
10.6. South and Central America Neurovascular Embolization Devices Market Size Outlook by Application
10.7. South and Central America Neurovascular Embolization Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neurovascular Embolization Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neurovascular Embolization Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neurovascular Embolization Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neurovascular Embolization Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neurovascular Embolization Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Type
11.6. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Application
11.7. Middle East and Africa Neurovascular Embolization Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neurovascular Embolization Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neurovascular Embolization Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neurovascular Embolization Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neurovascular Embolization Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neurovascular Embolization Devices Industry
Medtronic plc
Stryker Corporation
Johnson & Johnson (Cerenovus)
Penumbra, Inc.
Terumo Corporation (MicroVention)
Boston Scientific Corporation
MicroPort Scientific Corporation
Balt SAS
phenox GmbH
Medikit Co., Ltd.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
